CS logo
small CS logo
Hamzavi Dermatology

Fort Gratiot, Michigan, United States
Dermatologist in Fort Gratiot Township, Michigan
2950 Keewahdin Rd, Fort Gratiot Twp, MI 48059

About Hamzavi Dermatology


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Galderma R&D
6
Janssen Research & Development, LLC
5
Pfizer
4
Dow Pharmaceutical Sciences
3
LEO Pharma
3
Almirall, S.A.
2
Bristol-Myers Squibb
2
Eli Lilly and Company
2
Maruho Co., Ltd.
2
Peplin
2
Amgen
1
Total Rows: 22

Clinical Trials at Hamzavi Dermatology


During the past decade, Hamzavi Dermatology conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 18 clinical trials were completed, i.e. on average, 90% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 9 clinical trials were completed. i.e. 180% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years22223366221122221111331133116622Started TrialsCompleted Trails2015201620172018201920202021202202468
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study to Demonstrate the Efficacy and Safety of Adapalene/Benzoyl Peroxide Topical Gel in Subjects With Acne Vulgaris
2006-10-01
2007-12-01
Completed
1,670
A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis
2005-05-25
2019-01-31
Terminated
8,071
Psoriasis Longitudinal Assessment and Registry
2007-06-21
2030-12-31
Recruiting
16,000
Clinical Study to Test the Efficacy and Safety of Adapalene, 0.1%
2007-11-01
2008-11-01
Completed
1,075
A Clinical Study Evaluating the Safety and Efficacy of IDP-107 in Patients With Acne Vulgaris
2008-01-01
2009-09-01
Completed
366
A Multi-center Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel, When Used to Treat Actinic Keratoses on the Head (Face or Scalp)
2009-06-01
2009-09-01
Completed
269
A Long Term Follow up Study of Patients Who Have Completed the PEP005-016 or PEP005-025 Studies
2009-08-01
2010-10-01
Completed
117
Efficacy and Safety of CIP-Isotretinoin in Patients With Severe Recalcitrant Nodular Acne
2009-09-01
2011-05-01
Completed
925

Rows per page:

1–43 of 43

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Hamzavi Dermatology" #1 sponsor was "Galderma R&D" with 6 trials, followed by "Janssen Research & Development, LLC" with 5 trials sponsored, "Pfizer" with 4 trials sponsored, "Dow Pharmaceutical Sciences" with 3 trials sponsored and "LEO Pharma" with 3 trials sponsored. Other sponsors include 17 different institutions and companies that sponsored additional 22 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Hamzavi Dermatology" #1 collaborator was "Incyte Corporation" with 2 trials as a collaborator, "Allergan" with 1 trials as a collaborator, "Athenex, Inc." with 1 trials as a collaborator, "Database Integrations, Inc." with 1 trials as a collaborator and "Innovaderm Research Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.
Created with Highcharts 11.1.0Top Leading Sponsors

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Hamzavi Dermatology


According to Clinical.Site data, the most researched conditions in "Hamzavi Dermatology" are "Psoriasis" (9 trials), "Acne Vulgaris" (8 trials), "Atopic Dermatitis" (5 trials), "Plaque Psoriasis" (5 trials) and "Actinic Keratosis" (3 trials). Many other conditions were trialed in "Hamzavi Dermatology" in a lesser frequency.

Clinical Trials Intervention Types at Hamzavi Dermatology


Most popular intervention types in "Hamzavi Dermatology" are "Drug" (40 trials), "Combination Product" (2 trials) and "Other" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (10 trials), "Abrocitinib 200 mg" (2 trials), "BMS-986165" (2 trials), "Baricitinib" (2 trials) and "CP-690,550" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Hamzavi Dermatology


The vast majority of trials in "Hamzavi Dermatology" are 41 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Clinical Trials Status at Hamzavi Dermatology


Currently, there are NaN active trials in "Hamzavi Dermatology". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 35 completed trials in Hamzavi Dermatology, undefined suspended trials, and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Hamzavi Dermatology, 1 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 25 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By Phase

Created with Highcharts 11.1.0Trials Status